Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
For the full year,net profit rose 102.40% to Rs 55.64 crore in the year ended March 2026 as against Rs 27.49 crore during the previous year ended March 2025. Sales rose 6.91% to Rs 332.60 crore in the year ended March 2026 as against Rs 311.10 crore during the previous year ended March 2025.
Hester Biosciences is one of the leading animal health care companies & the second-largest poultry vaccine manufacturer in India.
The company's consolidated net profit surged 76.2% to Rs 14.45 crore on a 15.2% drop in revenue from operations to Rs 70.97 crore in Q2 FY26 over Q2 FY25.
Shares of Hester Biosciences rose 0.59% to Rs 1,672 on the BSE.